Cargando…
O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice
Non-alcoholic fatty liver disease is recognized as the leading cause of chronic liver disease. Overnutrition and obesity are associated with hepatic steatosis. G protein-coupled receptor 55 (GPR55) has not been extensively studied in hepatic steatosis, although its endogenous ligands have been impli...
Autores principales: | Kang, Saeromi, Lee, Ae-Yeon, Park, So-Young, Liu, Kwang-Hyeon, Im, Dong-Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003045/ https://www.ncbi.nlm.nih.gov/pubmed/33803038 http://dx.doi.org/10.3390/ijms22063091 |
Ejemplares similares
-
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice
por: Li, Kun, et al.
Publicado: (2013) -
A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors
por: Wróbel, Andrzej, et al.
Publicado: (2020) -
O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment
por: Wróbel, Andrzej, et al.
Publicado: (2020) -
GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
por: Im, Dong-Soon
Publicado: (2021) -
The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis
por: Moon, Young-Ah
Publicado: (2017)